...
机译:PSAID12临时核准2018年作为核心结果措施,以评估临床试验中的银屑病关节炎特异性健康相关生活质量
Johns Hopkins Univ Sch Med Div Rheumatol Baltimore MD 21224 USA;
Royal Prince Alfred Hosp Med Ctr Sydney NSW Australia;
Singapore Gen Hosp Dept Rheumatol &
Immunol Singapore Singapore;
Royal Natl Hosp Rheumat Dis Bath Avon England;
Kezar Life Sci San Francisco CA USA;
Bispebjerg &
Frederiksberg Hosp Parker Inst Copenhagen Denmark;
Royal Natl Hosp Rheumat Dis Bath Avon England;
Sorbonne Univ Paris France;
Vrije Univ Amsterdam Med Ctr Patient Res Partner Amsterdam Netherlands;
Bispebjerg &
Frederiksberg Hosp Parker Inst Copenhagen Denmark;
Univ Oxford Nuffield Dept Orthopaed Rheumatol &
Musculoskelet Oxford England;
Swedish Med Ctr Rheumatol Res Seattle WA USA;
Global Patient Outcomes &
Real World Evidence Indianapolis IN USA;
Pfizer Inc Global Med Affairs Montreal PQ Canada;
Univ Coll Dublin Dept Rheumatol St Vincents Univ Hosp Dublin Ireland;
Univ Penn Philadelphia PA 19104 USA;
Univ Ottawa Ottawa Hosp Res Inst Clin Epidemiol Program Ottawa ON Canada;
Univ Utah Dept Dermatol Salt Lake City UT USA;
Univ Ottawa Div Rheumatol Dept Med Ottawa ON Canada;
Univ Toronto Musculoskeletal Hlth &
Outcomes Res St Michaels Hosp Toronto ON Canada;
Univ Hlth Network Krembil Res Inst Toronto ON Canada;
PSORIATIC ARTHRITIS; CORE SET; OUTCOME MEASURES; OMERACT; GRAPPA;
机译:PSAID12临时核准2018年作为核心结果措施,以评估临床试验中的银屑病关节炎特异性健康相关生活质量
机译:根据认可的ASAS / OPERACT核心结果组评估轴向脊椎关节炎的干预效果:Cochrane评论中包含的试验的META研究研究
机译:骨科医生进行全关节置换预后临床试验的OMERACT核心域草案共识:国际公认的TJR试验(I-COMiTT)组预后评估报告
机译:精神分裂症门诊患者的长期奥拉扎滨治疗:其对生命与临床结果的影响
机译:基于项目响应理论的癌症临床试验中与健康相关的生活质量数据分析。
机译:患者对风湿病治疗措施(OMERACT)全关节置换(TJR)临床试验草案核心领域认可的认可
机译:PSAID12临时核准2018年作为核心结果措施,以评估临床试验中的银屑病关节炎特异性健康相关生活质量